Product Information
RIVASTIGMINE 4.5 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2058 per EA under NDC 65862065060. Its NADAC has been published 451 times since Nov 8, 2017.
Strength
4.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862065060
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIVASTIGMINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA204572On Market Since
3/25/2016
Pharmacological Classes
Price Statistics
The NADAC for RIVASTIGMINE 4.5 MG CAPSULE has been published 451 times since Nov 8, 2017, and over the history we have for it it has declined 78.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2058 per EA |
|---|---|
| All-time high | $0.9662 (Nov 15, 2017) |
| All-time low | $0.1780 (Jul 17, 2024) |
| 52-week high | $0.2215 |
| 52-week low | $0.1871 |
| Median price | $0.2830 |
| Average price | $0.3274 |
| Largest weekly change | +103.3% (Jan 20, 2021) |
| Weeks tracked | 451 |
| Tracking since | Nov 8, 2017 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIVASTIGMINE 4.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 4.5 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.2058 per EA (NDC 65862065060), effective Jun 24, 2026.
How has the price of RIVASTIGMINE 4.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIVASTIGMINE 4.5 MG CAPSULE has declined 78.7%. It has been tracked across 451 weekly CMS publications since Nov 8, 2017.
What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 4.5 MG CAPSULE?
Since Nov 8, 2017, the NADAC for RIVASTIGMINE 4.5 MG CAPSULE has ranged from a low of $0.1780 (Jul 17, 2024) to a high of $0.9662 (Nov 15, 2017), with a median of $0.2830 per EA.
Are there cheaper alternatives to RIVASTIGMINE 4.5 MG CAPSULE?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RIVASTIGMINE 4.5 MG CAPSULE, is $0.1992 per EA — about 3% below RIVASTIGMINE 4.5 MG CAPSULE.
Who manufactures RIVASTIGMINE 4.5 MG CAPSULE?
RIVASTIGMINE 4.5 MG CAPSULE (NDC 65862065060) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification